WA
VRTX icon

WP Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

WP Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Sell
2,945
-73
-2% -$34K 0.34% 43
2025
Q4 		$1.37M Sell
3,018
-190
-6% -$81.9K 0.34% 43
2025
Q3 		$1.26M Hold
3,208
– – 0.32% 42
2025
Q2 		$1.43M Buy
3,208
+9
+0.3% +$4.15K 0.39% 41
2025
Q1 		$1.55M Hold
3,199
– – 0.52% 36
2024
Q4 		$1.29M Hold
3,199
– – 0.43% 43
2024
Q3 		$1.49M Sell
3,199
-845
-21% -$406K 0.54% 40
2024
Q2 		$1.9M Sell
4,044
-100
-2% -$43.4K 0.61% 36
2024
Q1 		$1.73M Sell
4,144
-70
-2% -$29.6K 0.57% 38
2023
Q4 		$1.71M Sell
4,214
-337
-7% -$124K 0.63% 34
2023
Q3 		$1.58M Sell
4,551
-34
-0.7% -$11.9K 0.65% 35
2023
Q2 		$1.61M Sell
4,585
-417
-8% -$141K 0.65% 34
2023
Q1 		$1.58M Hold
5,002
– – 0.65% 37
2022
Q4 		$1.44M Sell
5,002
-705
-12% -$215K 0.65% 36
2022
Q3 		$1.65M Buy
5,707
+18
+0.3% +$5.18K 0.75% 32
2022
Q2 		$1.6M Hold
5,689
– – 0.7% 32
2022
Q1 		$1.49M Sell
5,689
-50
-0.9% -$11.9K 0.61% 37
2021
Q4 		$1.26M Sell
5,739
-738
-11% -$144K 0.52% 44
2021
Q3 		$1.18M Buy
6,477
+3,002
+86% +$586K 0.48% 44
2021
Q2 		$701K Buy
3,475
+252
+8% +$52.7K 0.29% 55
2021
Q1 		$693K Buy
3,223
+1,333
+71% +$293K 0.3% 49
2020
Q4 		$447K Buy
+1,890
New +$434K 0.22% 64
2018
Q3 		– Sell
-50
Closed -$8K – 283
2018
Q2 		$8K Buy
+50
New +$7.75K 0.01% 234

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WP Advisors's VRTX Position: Q1 2026 in Review

WP Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q1 2026, selling an estimated $34K and leaving 2,945 shares worth $1.32M. The position accounts for 0.34% of the portfolio, ranked #43.

WP Advisors first reported a position in VRTX in Q2 2018 and has held it in 23 quarters since. The position peaked at $1.9M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • WP Advisors held 2,945 shares of Vertex Pharmaceuticals worth $1.32M as of Q1 2026.
  • WP Advisors sold 73 Vertex Pharmaceuticals shares in Q1 2026, an estimated $34K.
  • Vertex Pharmaceuticals made up 0.34% of WP Advisors's portfolio in Q1 2026, its #43 holding.
  • WP Advisors first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 23 quarters since.
  • WP Advisors's Vertex Pharmaceuticals position peaked at $1.9M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.